Fisher Asset Management’s Day One Biopharmaceuticals DAWN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.44M | Sell |
221,983
-53,224
| -19% | -$346K | ﹤0.01% | 631 |
|
|
2025
Q1 | $2.18M | Buy |
275,207
+186,075
| +209% | +$1.48M | ﹤0.01% | 569 |
|
|
2024
Q4 | $1.13M | Buy |
89,132
+15,831
| +22% | +$201K | ﹤0.01% | 645 |
|
|
2024
Q3 | $1.02M | Hold |
73,301
| – | – | ﹤0.01% | 657 |
|
|
2024
Q2 | $1.01M | Buy |
73,301
+4,890
| +7% | +$67.4K | ﹤0.01% | 679 |
|
|
2024
Q1 | $1.13M | Sell |
68,411
-35
| -0.1% | -$578 | ﹤0.01% | 670 |
|
|
2023
Q4 | $999K | Buy |
68,446
+32,238
| +89% | +$471K | ﹤0.01% | 690 |
|
|
2023
Q3 | $444K | Hold |
36,208
| – | – | ﹤0.01% | 863 |
|
|
2023
Q2 | $432K | Hold |
36,208
| – | – | ﹤0.01% | 885 |
|
|
2023
Q1 | $484K | Sell |
36,208
-18
| -0% | -$241 | ﹤0.01% | 860 |
|
|
2022
Q4 | $780K | Sell |
36,226
-9,300
| -20% | -$200K | ﹤0.01% | 800 |
|
|
2022
Q3 | $912K | Buy |
+45,526
| New | +$912K | ﹤0.01% | 689 |
|